Abstract. Deep Vein thrombosis is very common in spinal cord injury patients, and a randomized study comparing the prophylactic use of external pneumatic calf compression, aspirin and dipyridamole has been carried out.
DEEP vein thrombosis (DVT) occurs frequently in patients with a history of recent trauma or surgery, especially when followed by prolonged immobilisation (Sevitt & Gallagher, 1961; Sevitt, 1969) . Therefore, it would be anticipated that the incidence of DVT would be high in individuals with acute spinal cord injury (SCI). Recently, we reported the presence of DVT in 13 of 18 consecutive patients with complete lower limb paralysis (Rossi et at., 1980) . As compared to those without thrombosis, patients with DVT had more elevated levels of the von Willebrand factor (ristocetin-cofactor, VIII: RCof ) and factor VIII related antigen (VIIIR: Ag), hyperactive platelet aggregation responses to collagen, and the appearance of circulating platelet aggregates coincident with the detection of thrombosis. We have now had the opportunity of examining the effect of prophy lactic measures on the incidence of DVT and the above-mentioned haemostatic factors.
Methods
A prospective clinical trial of DVT prophylaxis was carried out in 28 con secutive patients with acute SCI and complete lower limb paralysis; all were male except four. Subjects were randomised to one of two regimens: external pneu matic calf compression (EPCC) alone in IS, and EPCC combined with aspirin (ASA), 300 mg bid, and dipyridamole (Dip) 75 mg tid in 13. EPCC was admini stered using a Jobst Athrombic Pump (Model 66-20, Toledo, Ohio) set for I min cycles with IS sec calf compression at 40-45 mmHg.
DVT was detected by daily monitoring of the legs for the local uptake of 125I-Iabelled fibrinogen (Abbott Scientific Products, N. Chicago, Illinois). The thyroid was blocked with SSKI, and fibrinogen injections were given at approxi mately la-day intervals to maintain statistically meaningful count rates. Impedance plethysmography was performed on admission and every 72 hours thereafter. All positive tests were confirmed by contrast venography. Haematological studies were obtained within 72 hours of spinal cord injury and repeated at 3-day intervals for a period of I month. Platelet aggregation studies were performed according to the method of Born (1962) using soluble collagen prepared as we have previously described (Green et al., 1973) . The amount of collagen required to produce half-maximal aggregation velocity (Kd) was measured as reported by us previously (Rossi & Louis, 1977) . Circulating platelet aggregates (platelet aggregate ratio) were assessed as described by Wu and Hoak (1974) . VIII: C was assayed by Denson's modification (1966) of the method of Biggs et al. (1955) , VIII: RCoF by the method of Weiss et al. (1973) , and VIIIR: Ag by the Laurell technique (1972) . Laboratory personnel were unaware of the prophylactic regimen the patients were receiving.
Results

Incidence of DVT
One of the 13 patients randomised to receive ASAjdipyridamole was trans ferred to another facility on day 14 of the trial, and therefore was not included in the data analysis; thrombosis had not been detected in this patient up to the time of transfer. Of the remaining 27 patients completing the study, DVT was detected in nine (33 per cent), an incidence significantly less than the 78 per cent we previously recorded in 37 patients not receiving prophylaxis (X2 = II·33, p< 0·001). Although these untreated patients were not studied concurrently with those on prophylaxis, the criteria for case recruitment, the laboratory procedures, and the methods of management (aside from the prophylaxis), were identical. The thrombi in patients not receiving prophylaxis were generally diagnosed between days 4 and 12 after injury, whereas the peak incidence of DVT in the treated patients was between days 7 and IS (Fig. I) . Thrombi developed in six of IS patients treated solely with EPCC, and in three of 12 receiving ASAj dipyridamole as well as EPCe. This difference was not statistically significant (X2 = 0·17, P < 0·1). The six thrombi in the EPCC group were evenly divided between the popliteal and calf veins; of the three thrombi in the ASAjdip subjects, one was in the popliteal area and two were in the calf. None were in more proximal veins. In contrast, 23 per cent of the thrombi in our untreated patients were in the ilio-femoral veins. Prophylaxis was discontinued on day 30 after injury, but in three patients DVT developed on days 34 and 35. Two of these patients had been treated with EPCC and ASAjdipyridamole, and one had received EPCC alone.
Haemostatic Studies
Platelet Aggregation
The platelet aggregate ratios (PAR) of treated and previously untreated patients were initially within the normal range, but by day 6 had declined in the untreated group, and remained significantly reduced for the next 10 days (Fig. 2) . No differences were observed in the PAR of patients treated with EPee alone or EPee combined with aspirin and dipyridamole. The amount of collagen required to produce half-maximal aggregation velocity (Kd) was also reduced in untreated patients beginning on day 4 (Fig. 2) , and this increased platelet responsiveness to collagen persisted throughout the entire study. In treated patients (excluding those receiving aspirin and dipyri damole), the Kd was generally within the low normal range, but was not signifi cantly different from the untreated group except on days 4-6 and 28-30.
Factor VIII Activities Factor VIII coagulant actlVlty (VIII: C), ristocetin cofactor activity (VIII: Reo F), and VIII -related antigen (VIIIR: Ag) in the untreated patlents were all significantly increased above the values for treated patients (and normal subjects) from the seventh through the twelfth day after injury. An examination of the factor VIII levels of patients treated with EPee alone as compared to those also receiving aspirin and dipyridamole revealed that the latter in general had lower levels, although these reached statistical significance only for factor VIII related antigen during days 13-15 (Fig. 3) .
Side Effects
One subject who required cervical spine fusion while receiving aspirin and dipyridamole bled extensively during surgery and required I500 ml of blood replacement. No untoward effects were observed in the remainder of the patients. 
Discussion
Our previous studies (Rossi et al., 1980) indicated that patients with acute spinal cord injury had an extraordinarily high incidence of DVT. Therefore, prophylactic measures to reduce the risk of DVT in this high risk patient population were considered justified. External pneumatic calf compression has previously been shown to be safe and effective in decreasing the incidence of DVT in patients undergoing surgical procedures (Hills et ai., 1972; McKenna et ai., 1980) , and it was therefore applied to all our patients. The rationale for the addition of aspirin and dipyridamole to EPCC was based on several factors. Firstly, Walsh et ai. (1976) showed that coagulant activities attributable to platelets play an important role in the pathogenesis of DVT in patients undergoing hip surgery. Platelet coagulant and anti-heparin activities increased progressively and significantly in patients developing DVT, whereas no changes were observed in those without DVT. Our own studies in the SCI patients confirm these observations. Platelet affinity for collagen progressively increased in untreated patients, 78 per cent of whom subsequently developed DVT. Secondly, Salzman et al. (1971) reported that the incidence of DVT in patients undergoing hip arthroplasty was reduced from 34 per cent to 9 per cent (p < 0'02) by aspirin prophylaxis, and similar results were reported in a study of subjects undergoing total knee replacement (McKenna et al., 1980) . Thus, it appeared that the addition of aspirin might fu rther enhance the effectiveness of EPCC. However, both of the aforementioned studies suggested that relatively large doses of aspirin would be required (0·6 G twice daily and 1'3 G thrice daily, respectively). We were reluctant to give doses of this magnitude to our patients with SCI in view of the high incidence of haemorrhagic gastritis in these patients; therefore, we combined small doses of aspirin with dipyridamole since it has been hypothesised that the two agents may act synergistically to inhibit platelet fu nction (Moncada & Vane, 1979) . The results of our study indicate that EPCC alone reduces the incidence of DVT from 78 per cent to 40 per cent, and that the addition of ASA/dipyridamole results in a further reduction to 25 per cent. Furthermore, the onset of DVT is delayed by these prophylactic measures and thrombi were not detected in the ilio-femoral veins. However, while EPCC was well-tolerated by our patients, one subject receiving ASA/dipyridamole experienced significant bleeding during surgery, suggesting that these drugs should be used with caution if invasive procedures are contemplated.
HaemQstatic studies showed that the increased platelet-collagen affinity, circulating platelet aggregates, and elevated factor VIII activities which are observed in untreated patients, are partially prevented by the use of EPCC alone. Calf compression may disperse the unusually high local concentrations of factors II, V, and VIII in limbs where venous stasis is present (Houghton et al., 1978) preventing the local generation of thrombin and thrombin-induced platelet activation. The addition of ASA/dipyridamole to EPCC further normalises the haemostatic fa ctors with a corresponding reduction in DVT. Thus, these prophy lactic measures provide an effective deterrent against thrombosis in the spinal cord-injured patient.
SUMMARY
Twenty-eight consecutive patients with acute spinal cord injury were random ised to one of two regimens for the prevention of deep vein thrombosis (DVT): external pneumatic calf compression (EPCC, 15), or EPCC combined with aspirin, 300 mg bid, and dipyridamole, 75 mg tid (ASA/dip, 13). DVT, detected by the 125I-fibrinogen test and impedence plethysmography, was confirmed by contrast venography. The incidence of DVT in the total group was 33 per cent, signifi cantly less than the 78 per cent observed in 37 untreated patients studied previously (P < O·OOI). DVT developed in six of 15 patients receiving only EPCC, and three of 12 on ASA/dip as well as EPCC (P < O·I).
The untreated patients studied earlier had significantly increased circulating platelet aggregates, increased platelet affinity for collagen, and elevated factor VIII activities, which generally coincided with the development of DVT (usually 7-9 days after injury). Prophylaxis partially prevented these coagulation abnormalities and delayed the onset of thrombosis. While the differences in the haemostatic parameters between those not treated with ASA/dip and those receiving these agents were not statistically significant (except for the platelet-collagen affinity), there was a trend toward less elevated values in the drug-treated patients. We conclude that spinal cord injury patients are at extreme risk f or DVT, and have abnormal platelet and f actor VIII activities. Prophylaxis with EPCC significantly and sa f ely reduces the risk o f DVT in these patients.
RESUME
Vingt huit mala des admis de fa�on consecutive a la suite d'une lesion aigue de la colonne vertebrale ont ete soumis au hasard a l'un des deux regimes suivants pour prevenir la thrombo-phlebite: compression pneumatique ext erne du mollet (CPEM, IS cas) et CPEM associe au traitement a l'aspirine, 380 mg 2 fois par jour, et au dipyridamole, 75 mg 3 fois par jour (ASP/DIP). La thrombo-phlebite, detectee par les tests du fibrinogene iodine radioactif et de 'impedence plethysmography', a ete confirmee par la veinography de contraste. L'incidence de thrombo-phlebite dans Ie groupe entier est de 33 %, bien moindre que celle de 78 % observee dans 37 cas non-traites etudies auparavant (P < 0,001). La thrombo-phlebite s'est developpee dans 6 cas sur IS recevant la CPEM et dans 3 cas sur 12 recevant Ie traitement combine CPEM/ ASP /D IP.
Les mala des non-traites etudies auparavant ont une augmentation significative d'aggregats plaquettaires circulants, une affinite accrue des plaquettes pour Ie collagene et une augmentation des activites du facteur VIII qui coincident en general avec Ie develop ment de la thrombo-phlebite (en general 7-9 jours apres la lesion).
Le traitement prophylactique previent partiellement les anomalies de coagulation et retarde l'initiation de la thrombose. Bien que les parametres d'hemostase des mala des traites 11 l'ASP/DIP et de ceux non-traites ne soient pas bien differents (exception faite pour l'affinite plaquettes collagene), une tendance a des taux moins eleves cst notee chez les mala des sous-traitement. En conclusion, les malades presentant une lesion aigue de la colonne vertebrale risquent fort la thrombo-phlebite et ont une fonction plaquettaire anormale aussi bien que des taux Cleves du facteur VIII. Le traitement prophylactique de CPEM reduit de fac;on significative et sans danger Ie risque de thrombo-phlebite chez ces malades.
ZUSAMMENFASSUNG
Achtundzwanzig aufeinanderfolgende Patienten mit akuter Riickenmarkverletzung wurden aufs Geratewohl in zwei Disziplinen eingeteilt zur Verhinderung von Thrombose in tief gelegenen Venen: externe pneumatische Wadenkompression, oder externe pneu matische Wadenkompression mit Aspirin, 300 mg bid, und Dipyridamole, 75 mg tid (ASA/dip, 13). Thrombose in tief gelegenen Venen, festgestellt mit dem 125I-Fibrinogen Test und Plethysmographie wurde durch Kontrastvenographie bestatigt. 33 % aller Falle entwickelten Venenthrombosen, bedeutend weniger als 78 % von 37 nicht behandelten Patient en, die vorher getestet wurden (P < 0·00I). Tief gc1egene Venenthrombose entstand in 6 von IS Patienten, die nur externe pneumatische Wadenkompression erhic1ten und in 3 von 12, die mit Aspirin/dip und Wadenkompressen behandelt wurden (P < 0·I).
Unbehandc1te Patienten, die vorher getestet wurden, hatten zirkulierende Thrombo zyten Aggregate, erhohte Thrombozyten-Kollagen Affinitat und erhohte Faktor VIII Aktivitat, was im algemeinen im Zusammenhang stand mit der Entstehung von Thrombosen (gewonlich 7-9 Tage nach der Verletzung). Prophylaxe verhinderte teilweise diese Gerinnungsabnormalitaten und verschob den Beginn der Thrombose. Wahrend die Unterschiede in den hamostatischen Parametern zwischen der mit ASA/dip behandelten Gruppe und den Patienten die keine Medikamenten erhielten nicht statistisch von Bedeu tung sind (auf3er der Thrombozyten-Kollagen Affinitat) zeigte sich cine Tendenz zu niedrigeren Werten in den mit Medikamenten behandelten Patienten. \Vir beschlief3en, daf3 riickenmarkge1ahmte Patient en in auf3erster Gefahr sind Thrombosen zu entwickeln und abnormale Thrombozyten und Faktor VIII Aktivitat haben. Prophylaxe mit externer pneumatischer Wadenkompression reduziert bedeutend und sicher die Gefahr von Venenthrombosen in diesen Patienten.
